51 – 60 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The NF-κB-modulated miR-19a-3p enhances malignancy of human ovarian cancer cells through inhibition of IGFBP-3 expression
- Contribution to journal › Article
-
Mark
Development and validation of circulating CA125 prediction models in postmenopausal women
- Contribution to journal › Article
- 2018
-
Mark
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
- Contribution to journal › Article
-
Mark
Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels : Results from the EPIC cohort
- Contribution to journal › Article
-
Mark
Prophylactic 3-hour graduated infusion schedule minimizes risk of carboplatin hypersensitivity reactions - A prospective study
- Contribution to journal › Article
-
Mark
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
- Contribution to journal › Article
-
Mark
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
- Contribution to journal › Article
-
Mark
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer : A Review of the Current Literature
- Contribution to journal › Scientific review
- 2017
-
Mark
Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models : results from the EPIC cohort
- Contribution to journal › Article
-
Mark
Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation
- Contribution to journal › Article
